Compare ADMA Biologics Inc (ADMA) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Marathon Digital Holdings Inc — how do they compare? ADMA Biologics Inc trades at $12.72 (market cap $2.82B), while Marathon Digital Holdings Inc trades at $6.34 (market cap $2.45B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ADMA Biologics Inc for 19 Days and Marathon Digital Holdings Inc for 25 Days on average.
| ADMA | MARA | |
|---|---|---|
Market Cap | $2.82B | $2.45B |
Volume | 4,647,306 | 34,591,432 |
Sector | Health | Financials |
52-Week High | $20.38 | $15.87 |
52-Week Low | $7.60 | $5.88 |
Typical Hold Time | 19 Days | 25 Days |
Enterprise Value | $2.90B | $4.50B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $12.73, down 3.63% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a net income margin of 35.14% and ROE of 41.95% for 2025. Recent earnings showed mixed results, with Q3 2026 beating expectations. Analyst consensus is strongly bullish with a $19.50 price target, indicating significant upside potential from current levels.
The outlook remains positive given robust fundamentals and analyst support, but risks include legal investigations into fiduciary duties and recent stock volatility. Revenue growth to $519 million in 2026 and improved cash flow trends support the bullish case, though investor sentiment is cautious amid negative news flow.
MARA stock trades at $6.35, up 8.09% on the day, but faces significant fundamental challenges with a net income margin of -429.71% and three consecutive quarterly earnings misses. Technical indicators show a bearish trend with the stock trading near support at $6, while analyst consensus remains divided with a $12.50 price target representing 97% upside potential from current levels.
The stock offers speculative upside based on analyst targets but carries substantial risk due to persistent losses and negative cash flow from operations. Investors must weigh the potential for Bitcoin-driven sentiment improvements against the company's fundamental weakness and high volatility exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
